Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study

OBJECTIVE: The prognosis of patients with relapsed or refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) is poor. Although patients who fail first‐line salvage chemotherapy are candidates for second‐line salvage chemotherapy, the optimal treatment strategy for these patients has not yet been est...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagi, Yu, Kanemasa, Yusuke, Sasaki, Yuki, Sei, Mina, Matsuo, Takuma, Ishimine, Kento, Hayashi, Yudai, Mino, Mano, Ohigashi, An, Morita, Yuka, Tamura, Taichi, Nakamura, Shohei, Okuya, Toshihiro, Shimizuguchi, Takuya, Shingai, Naoki, Toya, Takashi, Shimizu, Hiroaki, Najima, Yuho, Kobayashi, Takeshi, Haraguchi, Kyoko, Doki, Noriko, Okuyama, Yoshiki, Shimoyama, Tatsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523963/
https://www.ncbi.nlm.nih.gov/pubmed/37635630
http://dx.doi.org/10.1002/cam4.6412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523963/
https://www.ncbi.nlm.nih.gov/pubmed/37635630
http://dx.doi.org/10.1002/cam4.6412

Ejemplares similares